Literature DB >> 26984054

Therapy: A fine conception -- BSR/BHPR guidelines on drugs in pregnancy.

Lisa R Sammaritano1, Bonnie L Bermas2.   

Abstract

Medical management of women with rheumatic diseases during pregnancy is challenging owing to incomplete information regarding medication safety. The British Society for Rheumatology and the British Health Professionals in Rheumatology committee published consensus guidelines that provide a good first step towards narrowing the knowledge gap in this important field.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26984054     DOI： 10.1038/nrrheum.2016.27

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  9 in total

1.  BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice.

Authors:  Julia Flint; Sonia Panchal; Alice Hurrell; Maud van de Venne; Mary Gayed; Karen Schreiber; Subha Arthanari; Joel Cunningham; Lucy Flanders; Louise Moore; Amy Crossley; Neetha Purushotham; Amisha Desai; Madeleine Piper; Mohamed Nisar; Munther Khamashta; David Williams; Caroline Gordon; Ian Giles
Journal:  Rheumatology (Oxford)       Date:  2016-01-10       Impact factor: 7.580

2.  BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.

Authors:  Julia Flint; Sonia Panchal; Alice Hurrell; Maud van de Venne; Mary Gayed; Karen Schreiber; Subha Arthanari; Joel Cunningham; Lucy Flanders; Louise Moore; Amy Crossley; Neetha Purushotham; Amisha Desai; Madeleine Piper; Mohamed Nisar; Munther Khamashta; David Williams; Caroline Gordon; Ian Giles
Journal:  Rheumatology (Oxford)       Date:  2016-01-10       Impact factor: 7.580

3.  Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.

Authors:  Arthur Kavanaugh; John J Cush; Mahmoud S Ahmed; Bonnie L Bermas; Eliza Chakravarty; Christina Chambers; Megan Clowse; Jeffrey R Curtis; Kathryn Dao; Gary D V Hankins; Gideon Koren; Seoyoung C Kim; Larissa Lapteva; Uma Mahadevan; Thomas Moore; Martha Nolan; Zhaoxia Ren; Lisa R Sammaritano; Sally Seymour; Michael H Weisman
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-03       Impact factor: 4.794

Review 4.  The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease.

Authors:  C J van der Woude; S Ardizzone; M B Bengtson; G Fiorino; G Fraser; K Katsanos; S Kolacek; P Juillerat; A G M G J Mulders; N Pedersen; C Selinger; S Sebastian; A Sturm; Z Zelinkova; F Magro
Journal:  J Crohns Colitis       Date:  2015-02       Impact factor: 9.071

5.  Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Part I.

Authors:  Miguel Ángel Saavedra Salinas; Antonio Barrera Cruz; Antonio Rafael Cabral Castañeda; Luis Javier Jara Quezada; C Alejandro Arce-Salinas; José Álvarez Nemegyei; Antonio Fraga Mouret; Javier Orozco Alcalá; Mario Salazar Páramo; Claudia Verónica Cruz Reyes; Lilia Andrade Ortega; Olga Lidia Vera Lastra; Claudia Mendoza Pinto; Antonio Sánchez González; Polita Del Rocío Cruz Cruz; Sara Morales Hernández; Margarita Portela Hernández; Mario Pérez Cristóbal; Gabriela Medina García; Noé Hernández Romero; María Del Carmen Velarde Ochoa; José Eduardo Navarro Zarza; Verónica Portillo Díaz; Angélica Vargas Guerrero; María Victoria Goycochea Robles; José Luis García Figueroa; Eduardo Barreira Mercado; Mary Carmen Amigo Castañeda
Journal:  Reumatol Clin       Date:  2015-01-29

6.  Use of tramadol in early pregnancy and congenital malformation risk.

Authors:  Bengt Källén; Margareta Reis
Journal:  Reprod Toxicol       Date:  2015-10-23       Impact factor: 3.143

Review 7.  State of the art: Reproduction and pregnancy in rheumatic diseases.

Authors:  Monika Østensen; Laura Andreoli; Antonio Brucato; Irene Cetin; Christina Chambers; Megan E B Clowse; Nathalie Costedoat-Chalumeau; Maurizio Cutolo; Radboud Dolhain; M H Fenstad; Frauke Förger; Marie Wahren-Herlenius; Guillermo Ruiz-Irastorza; Hege Koksvik; Catherine Nelson-Piercy; Yehuda Shoenfeld; Angela Tincani; Peter M Villiger; Marianne Wallenius; Michael von Wolff
Journal:  Autoimmun Rev       Date:  2014-12-30       Impact factor: 9.754

8.  Newer-generation antiepileptic drugs and the risk of major birth defects.

Authors:  Ditte Mølgaard-Nielsen; Anders Hviid
Journal:  JAMA       Date:  2011-05-18       Impact factor: 56.272

9.  Pregnancy outcomes following exposure to abatacept during pregnancy.

Authors:  Monica Kumar; Laura Ray; Sudha Vemuri; Teresa A Simon
Journal:  Semin Arthritis Rheum       Date:  2015-06-26       Impact factor: 5.532
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.